• Products
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Trading Platforms
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Trading Platforms
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Share Market Today
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Stockshaala
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Stockshaala
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement

Trump Tariffs Impact on Indian Stocks: Sector-Wise Analysis & Market Outlook

  •  4 min read
  • 0
  • 1d ago
Trump Tariffs Impact on Indian Stocks: Sector-Wise Analysis & Market Outlook

US President Donald Trump’s push to bring back reciprocal tariffs—taxes on countries that charge higher duties on American goods has brought global trade into the spotlight. If it goes through, it could change the way global trade flows—at least in the short to medium term.

India is one of the countries in the spotlight. The 26% duty on a range of Indian products is being seen as a strong protectionist move. Several of its export-heavy sectors now face the challenge of dealing with a complex new tariff structure.

For Indian stocks, the impact could go both ways. Some sectors might feel the pressure right away. Others could find ways to adapt or even turn this into an opportunity.

Through this blog, we will look at which industries are most exposed and how this may play out in the markets.

India’s pharma sector has long been a major exporter to the US, especially in generic and essential medicines. But now, companies heavily dependent on the US for revenues may lose business and face losses.

This may particularly affect mid- to large-scale pharma companies exporting common drugs and formulations. If companies cannot absorb or pass on the additional cost burden, their margins could be pressured. The result could be a dip in short-term sentiment around select pharma stocks—even if long-term demand for medicines remains strong.

India’s two-wheeler and compact car segment does maintain a modest but strategic export relationship with the US. With tariffs raising the cost of these vehicles in the American market, manufacturers may have to reassess their export strategies.

Additionally, the auto components and ancillary industry—which supports global supply chains—may see disruptions. Increased input costs, changes in demand patterns, and shipment delays could all contribute to short-term volatility. Some companies may try to shift supply to less affected markets. However, uncertainty about US demand could keep auto stocks under pressure.

Of all the affected sectors, gems and jewellery—particularly the diamond trade—could face a significant hit. The US accounts for a large share of India’s polished diamond and jewellery exports.

Demand may fall sharply, especially as American buyers are very price-sensitive. The Indian jewellery sector, which relies heavily on global demand cycles, may experience a contraction in order volumes. This could have a cascading effect on smaller manufacturers and exporters, with the potential for visible strain in related stock performances.

While India’s steel exports to the US aren’t massive, they still matter—especially for large integrated steel companies. With tariffs increasing the landed cost of Indian steel in the US, competitiveness may be compromised.

The broader concern lies in how this policy move influences global steel pricing. Any oversupply from redirected exports could push prices down, even in markets where India still exports. Steel producers with global operations may need to adjust their trade strategies. Also, those heavily reliant on the US market could face pressure more quickly.

Right after the tariff news, Indian stock markets dropped. Sentiment around export-heavy stocks weakened, and foreign institutional activity slowed. Investors remain cautious, watching for follow-up actions and possible retaliatory moves.

However, the longer-term outlook may not be universally bleak. Some sectors, such as information technology and agriculture, could benefit from a shift in US import preferences. If supply chains shift away from some competing countries, India could become a new supplier. But this will depend on how global trade talks go and whether India can stay price competitive.

Besides the direct impact on exports, the tariffs also raise broader questions for macroeconomic indicators. Foreign exchange rates, trade deficit metrics, and inflationary pressures could all be influenced as the market absorbs the implications of these duties. Exporters might face working capital pressure. Meanwhile, companies focused on the domestic market may look more attractive in the short term.

That said, India’s diverse economic structure and strong domestic demand may help buffer against some of these external shocks. But the current scenario warrants closer scrutiny for companies—and by extension, their stocks—with a sizeable US dependency.

Trump’s reciprocal tariff plan has revived concerns about protectionism. India now faces a tough choice between following the rules and planning a strong response. For Indian equities, the ripple effect is most visible in sectors like pharmaceuticals, automobiles, gems and jewellery, and steel—each of which has some degree of exposure to the American market.

Short-term volatility is expected, but how companies respond—through cost cuts, exploring new markets, or engaging with policymakers—will likely shape the market’s direction in the coming months. For investors and traders, the coming weeks could reveal how well India’s export-focused industries adjust to changing global conditions.

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.

Did you enjoy this article?

0 people liked this article.

What could we have done to make this article better?

Open Your Demat Account Now!
+91 -

Open Your Demat Account Now!
+91 -

N
N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]